Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elliott Vichinsky

Showing results (101-110 of 132) with videos related to

Pageof 14
Sort By:
Pediatric Blood & Cancer|June 11, 2010
Education and employment status of children and adults with thalassemia in North AmericaZahra Pakbaz, Marsha Treadwell, Hae-Young Kim, et al.
Clinical Neuroradiology|October 28, 2021
Anterior Pituitary Volume in Patients with Transfusion Dependent Anemias: Volumetric Approaches and Relation to Pituitary MRI‑R2Christoph Berliner, Zhiyue J Wang, Sylvia T Singer, et al.
Journal of Pediatric Hematology/Oncology|January 25, 2003
Chlamydia pneumoniae and acute chest syndrome in patients with sickle cell diseaseDeborah Dean, Lynne Neumayr, Dana M Kelly, et al.
American Journal of Hematology|September 30, 2009
Hemoglobin H-constant spring in North America: an alpha thalassemia with frequent complicationsSylvia Titi Singer, Hae-Young Kim, Nancy F Olivieri, et al.
Acta Haematologica|April 15, 2008
Patient-reported outcomes of deferasirox (Exjade, ICL670) versus deferoxamine in sickle cell disease patients with transfusional hemosiderosis. Substudy of a randomized open-label phase II trialElliott Vichinsky, Zahra Pakbaz, Onyinye Onyekwere, et al.
British Journal of Haematology|May 20, 2011
Long-term safety and efficacy of deferasirox (Exjade) for up to 5 years in transfusional iron-overloaded patients with sickle cell diseaseElliott Vichinsky, Françoise Bernaudin, Gian Luca Forni, et al.
British Journal of Haematology|December 11, 2012
Increased leucocyte apoptosis in transfused β-thalassaemia patientsPatrick B Walter, John Porter, Patricia Evans, et al.
Blood|January 31, 2004
Stroke and conversion to high risk in children screened with transcranial Doppler ultrasound during the STOP studyRobert J Adams, Donald J Brambilla, Suzanne Granger, et al.
British Journal of Haematology|July 17, 2009
Differences in the prevalence of growth, endocrine and vitamin D abnormalities among the various thalassaemia syndromes in North AmericaMaria G Vogiatzi, Eric A Macklin, Felicia L Trachtenberg, et al.
British Journal of Haematology|January 20, 2007
A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell diseaseElliott Vichinsky, Onyinye Onyekwere, John Porter, et al.
Pageof 14

Showing results (101-110 of 132) with videos related to

Sort By:
Pageof 14
Pediatric Blood & Cancer|June 11, 2010
Education and employment status of children and adults with thalassemia in North AmericaZahra Pakbaz, Marsha Treadwell, Hae-Young Kim, et al.
Clinical Neuroradiology|October 28, 2021
Anterior Pituitary Volume in Patients with Transfusion Dependent Anemias: Volumetric Approaches and Relation to Pituitary MRI‑R2Christoph Berliner, Zhiyue J Wang, Sylvia T Singer, et al.
Journal of Pediatric Hematology/Oncology|January 25, 2003
Chlamydia pneumoniae and acute chest syndrome in patients with sickle cell diseaseDeborah Dean, Lynne Neumayr, Dana M Kelly, et al.
American Journal of Hematology|September 30, 2009
Hemoglobin H-constant spring in North America: an alpha thalassemia with frequent complicationsSylvia Titi Singer, Hae-Young Kim, Nancy F Olivieri, et al.
Acta Haematologica|April 15, 2008
Patient-reported outcomes of deferasirox (Exjade, ICL670) versus deferoxamine in sickle cell disease patients with transfusional hemosiderosis. Substudy of a randomized open-label phase II trialElliott Vichinsky, Zahra Pakbaz, Onyinye Onyekwere, et al.
British Journal of Haematology|May 20, 2011
Long-term safety and efficacy of deferasirox (Exjade) for up to 5 years in transfusional iron-overloaded patients with sickle cell diseaseElliott Vichinsky, Françoise Bernaudin, Gian Luca Forni, et al.
British Journal of Haematology|December 11, 2012
Increased leucocyte apoptosis in transfused β-thalassaemia patientsPatrick B Walter, John Porter, Patricia Evans, et al.
Blood|January 31, 2004
Stroke and conversion to high risk in children screened with transcranial Doppler ultrasound during the STOP studyRobert J Adams, Donald J Brambilla, Suzanne Granger, et al.
British Journal of Haematology|July 17, 2009
Differences in the prevalence of growth, endocrine and vitamin D abnormalities among the various thalassaemia syndromes in North AmericaMaria G Vogiatzi, Eric A Macklin, Felicia L Trachtenberg, et al.
British Journal of Haematology|January 20, 2007
A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell diseaseElliott Vichinsky, Onyinye Onyekwere, John Porter, et al.
Pageof 14